このパッケージに含まれるもの
医療処置
- 骨髄生検
- 小児科受診
- 神経芽細胞腫の複合診断
- 腫瘍専門医の診察
- 放射線科医による診察
- 神経芽細胞腫の複雑治療
- HIV抗体検査
- B型肝炎コア抗体検査
- 抗HCV抗体検査
- 血液検査
- 生化学血液検査
- 生検
- 胸部X線
- 全血球計算(CBC)
- 腫瘍専門医との診察
- 免疫専門医への相談
- 循環器科医への相談
- 小児血液専門医との相談
- 小児科医との相談
- 骨塩定量検査(CBM)
- 腫瘍マーカーおよび蛋白分画を含む全血球算定
- 心電図(ECG)
- 心エコー図検査
- 頭部MRI
- PET/CT
- 腫瘍血液専門医との診察
- 24時間看護サービス
- 栄養士による1日3食
期間
- 30 日 病院で
宿泊
入院
交通
空港-クリニック-空港間の送迎
追加情報
Bone Marrow Transplant for Pediatric Neuroblastoma
Sheba Medical Center – Advanced, Personalized Transplant Care for Children
At Sheba Medical Center, we understand how challenging it is for families to face a diagnosis of neuroblastoma. This complex childhood cancer requires not only advanced medical expertise, but also compassionate, family-centered care.
For children with high-risk or relapsed neuroblastoma, bone marrow transplantation (BMT) plays a vital role in treatment offering a powerful approach aimed at improving long-term outcomes and giving children the best possible chance for recovery.
Our pediatric transplant program combines world-leading expertise, innovative therapies, and a supportive environment designed specifically for children and their families.
When is a Bone Marrow Transplant Needed?
In neuroblastoma, bone marrow transplantation is typically part of an intensive treatment strategy and may be recommended when:
The disease is high-risk at diagnosis
Neuroblastoma has spread beyond the original tumor site
The disease returns after initial treatment
BMT allows doctors to use high-dose therapy to eliminate cancer cells, followed by the infusion of healthy stem cells to restore the bone marrow and immune system.
Types of Transplant
Autologous Transplant (Child’s Own Cells)
For most children with neuroblastoma, this is the standard approach.
Stem cells are collected from the child in advance
High-dose therapy is delivered to target remaining cancer cells
The child’s own cells are reinfused to rebuild healthy bone marrow
In selected cases, tandem (double) transplants may be recommended to further strengthen treatment outcomes.
Allogeneic Transplant (Donor Cells)
While autologous transplantation is the most common approach, Sheba Medical Center also offers advanced allogeneic (donor) transplantation for carefully selected cases.
This option may be considered for:
Children who need an alternative stem cell source
Children who require an additional therapeutic strategy after prior treatment
Donor Options at Sheba include:
Matched sibling donors, when available
Matched unrelated donors through international registries
Haploidentical (half-matched) family donors, often a parent
Sheba’s expertise allows access to the most suitable donor for every child, ensuring that no patient is left without options.
A unique advantage of donor transplantation is the graft-versus-tumor effect, where the new immune system can help recognize and fight any remaining neuroblastoma cells.
Precision Matching and Advanced Technology
Successful transplantation begins with the best possible donor match.
Sheba Medical Center operates an advanced on-site HLA laboratory, performing high-resolution genetic testing to ensure optimal compatibility between donor and child, enhancing safety and treatment effectiveness.
Advanced Pediatric Neuroblastoma Care
Sheba offers highly specialized treatment tailored to each child:
Personalized transplant protocols
Integration with immunotherapy and targeted treatments
Advanced supportive care to promote recovery
Close collaboration between pediatric oncology and transplant teams
Specialized Pediatric Transplant Environment
Children are treated in dedicated pediatric transplant units designed for safety, comfort, and healing:
Child-friendly, highly protected environments
Advanced infection prevention systems
Continuous care by experienced pediatric specialists
Every aspect of care is adapted to support children physically and emotionally.
Clinical Expertise
Sheba Medical Center is a leading center for pediatric cancer care, offering:
Extensive experience in high-risk neuroblastoma
Expertise in autologous and donor transplantation approaches
Strong outcomes aligned with leading international centers
Long-term follow-up focused on growth, development, and quality of life
Care That Supports the Whole Family
We understand that this journey involves the entire family.
At Sheba, children and their families are supported by a multidisciplinary team including physicians, nurses, psychologists, and care coordinators ensuring guidance, reassurance, and continuous support at every stage.
Why Families Choose Sheba for Pediatric BMT
Leading pediatric transplant center
Expertise in complex neuroblastoma cases
Access to a wide range of donor options
Advanced technologies and treatment approaches
Child-focused, compassionate care
Dedicated international patient services
A Message of Hope
At Sheba Medical Center, we combine innovation, expertise, and compassionate pediatric care to give every child the strongest possible chance for recovery, while supporting families with confidence, clarity, and hope every step of the way.
24時間年中無休Bookimedサポート
- 専任医療コーディネーター
- 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
- 医療旅行中の患者擁護
プログラム料金
このパッケージに含まれないもの
医師
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
調子はいかがですか?
クリニックについて
シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。